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Cardiac resynchronization therapy (CRT) has shown
to be an effective treatment for patients with advanced
heart failure (HF) (NYHA Class III or IV), reduced
left ventricular ejection fraction (LVEF\35%) and
wide QRS complexes ([120 ms) [1, 2]. The beneﬁcial
effects include improvement in heart failure symp-
toms, exercise capacity, and left ventricular function,
as well as less heart failure hospitalizations and lower
mortality rates. Despite these remarkable results, 30–
40% of patients show no beneﬁt after CRT, the so-
called ‘non-responders’ [3–5]. It remains, however,
difﬁcult to distinguish responders from non-respond-
ers in the early period after CRT. The presence of LV
dyssynchrony prior to implantation and its subsequent
reduction after implantation have been proposed as
the key mechanisms for a positive response to CRT
[6].
A variety of imaging modalities has already been
applied to identify dyssynchrony and to evaluate the
effects of CRT [7–10]. The use of echocardiography
[11–17], magnetic resonance imaging (MRI) [18–29],
and multi-slice computed tomography (MSCT) [30–
43] has recently been proven for patients eligible for
CRT. In addition, nuclear imaging techniques have
become suited for the evaluation of LV dyssynchrony
[44–51]. Until now, scintigraphic studies in CRT
mainly concerned radionuclide angiography with
phase image analysis [52–56]. In recent years posi-
tron emission tomography (PET) has emerged as a
suitable modality to study the metabolic mechanisms
of left ventricular dyssynchrony and the effects of
CRT. Several studies did already report that 11C-
acetate PET performed in the chronic phase after
CRT showed improvement of oxygen metabolism
and cardiac efﬁciency by CRT [57, 58].
In the current issue in the International Journal of
Cardiovascular Imaging, Zaca ´ et al. [59] provide an
interesting analysis about the selection of candidates
to CRT beyond responders and non-responders with
the perspective of the potential identiﬁcation of
patients who will not respond to CRT. The authors
clearly state that of all evaluated indices of mechan-
ical dyssynchrony only a QRS duration of[120 ms is
recommended in current treatment guidelines for
the selection of candidates to CRT. No conclusive
evidence is currently available about which of the
many variables can predict individual response and
should be included in selection criteria. The disap-
pointing results of the PROSPECT trial may be due
to high variability in tissue Doppler imaging (TDI)
measurements and pathophysiological issues poten-
tially affecting response to CRT mainly in ischemic
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DOI 10.1007/s10554-010-9664-6patients [60]. Zaca ´ et al. [59] challenge the view that
patients with ischemic cardiomyopathy and extensive
scar tissue should be withheld CRT. Several studies
by the group of Bax [29, 61, 62] have shown that the
presence of postero-lateral scar tissue diagnosed by
contrast-enhanced MRI resulted in ineffective CRT in
30–40% of patients with ischemic heart failure. Using
biventricular pacing, left ventricular dyssynchrony
remained unchanged, and there were no functional
improvements at 6 months follow-up. The results of
these studies have been conﬁrmed by many other
studies that showed a clear negative association
between scar burden and the response to CRT
[63–68]. Notwithstanding, it is the belief of Zaca ´
et al. [59] that these observations and the ensuing
implications not to treat with CRT are too prelimin-
ary. The value of CRT in this subset of ischemic heart
failure patients would mandate larger multi-center
studies. In their vision, even non-responders should
receive a CRT device whereby the certain risk of
withholding the treatment might be more consistent
than the potential risk of being a non-responder. This
point of view is in line with the recent study by
Riedlbauchova ´ et al. [69], who showed that the
response to CRT was independent of the presence of
extensive myocardial scarring. It was shown that left
ventricular pacing at sites with ischemia, hibernation,
or non-transmural scar did not appear to modify the
effect of CRT as compared to viable tissue. It follows
that incorporation in the standard selection criteria of
algorithms to predict the response to CRT is yet not
ready for clinical use. To this purpose, appropriate
application of sophisticated imaging techniques may
improve efﬁcacy of resynchronization in the subset
of ischemic patients who might respond to CRT.
Therefore, identiﬁcation of these individuals by means
of echocardiography, nuclear cardiology, MSCT or
MRI potentially has substantial implications in deﬁn-
ing the optimal strategy for device implantation. In this
respect, consistent data are likely to be expected from
echocardiographic studies using advanced measures of
mechanical dyssynchrony such as two-dimensional
strain imaging, speckle tracking, and real-time three-
dimensional echocardiography [15, 17, 70–76].
Although it appears legitimate to withhold CRT in
patients with ischemic cardiomyopathy who show
extensive scar tissue, a deﬁnite treatment policy in
these patients can only be fully embraced after
supportive data from large multi-center studies.
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